CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.

Glycoside Hydrolase Family 20

From CAZypedia
Jump to navigation Jump to search
Approve icon-50px.png

This page has been approved by the Responsible Curator as essentially complete. CAZypedia is a living document, so further improvement of this page is still possible. If you would like to suggest an addition or correction, please contact the page's Responsible Curator directly by e-mail.


Glycoside Hydrolase Family GH20
Clan GH-K
Mechanism retaining
Active site residues known
CAZy DB link
http://www.cazy.org/GH20.html


Substrate specificities

GH20 glycoside hydrolases comprise both eukaryotic and prokaryotic enzymes. In addition to exo-acting β-N-acetylglucosaminidases, β-N-acetylgalactosamindase and β-6-SO3-N-acetylglucosaminidases, GH20 also contains exo-acting lacto-N-biosidases that cleave β-D-Gal-(1→3)-D-GlcNAc disaccharides from the non-reducing end of oligosaccharides. The best known members of GH20 are the human isoenzymes hexosaminidase A (a heterodimer of α and β subunits) and B (a homodimer of β subunits), which are responsible for the hydrolysis of the terminal GalNAc residue from the GM2 ganglioside (GalNAcβ(1–4)-[NANAα(2–3)-]-Galβ(1–4)-Glc-ceramide) within the lysosome. Mutations to these enzymes are responsible for the lysosomal storage disorders Tay-Sachs disease (HEXA) and Sandhoff disease (HEXB). Inhibitors of these enzymes are being developed as chemical chaperones to promote the partial restoration of enzyme activity in vivo and treat these genetic disorders [1].

GM2 ganglioside is the natural target of human hexasaminidase A and B activity.

Kinetics and Mechanism

GH20 enzymes are retaining glycoside hydrolases [2]. Neighboring group participation has long been established as a reasonable mechanism for glycoside hydrolysis in solution[3, 4, 5, 6] and originally outlined as a possible, though subsequently refuted, mechanism for the hen egg-white lysozyme-catalyzed cleavage of β-aryl di-N-acetylchitobiosides [7]. The earliest kinetic evidence supporting a mechanism involving neighboring group participation in an enzyme-catalyzed hydrolysis [8, 9] can be found for an N-acetyl-β-D-glucosaminidase isolated from Aspergillus oryzae [10], likely a GH20 enzyme. This work used free energy relationships to infer neighbouring group participation although complete Michaelis-Menten kinetic parameters were not determined. Such kinetic parameters were determined for a β-N-acetylglucosaminidase from Aspergillus niger and a similar free energy relationship-based analysis carried out to infer neighbouring group participation for this enzyme which, though unknown, is likely from GH20 [11]. The potency of "NAG-thiazoline" as a competitive inhibitor of the jack bean (Canavalia spp) N-acetyl-β-D-hexosaminidase (Ki = 280 nM) has also been used to infer neighboring group participation in the catalytic mechanism although, interestingly, the only retaining hexosaminidases reported currently (November 2010) in the CAZy database for the genus Canavalia are found in GH18 [12].

Deacetylation of the non-reducing end of a series of chito-oligosaccharides results in a loss of activity of Serratia marscescens chitobiase, an established GH20 enzyme, towards these compounds, which instead act as competitive inhibitors [2]. Moreover the structure of Serratia marcescens chitobiase in complex with a substrate provides structural support for a substrate-assisted mechanism.

Competitive Inhibitors of hexosaminidases. "NAG-thiazoline" (upper panel) and non-reducing end deacetylated chito-oligosaccharides are competitive inhibitors of hexosamindase employing neighbouring group participation

A comparative analysis of the activity of Streptomyces plicatus β-hexosaminidase (SpHex, GH20) and Vibrio furnisii β-hexosaminidase (ExoII, GH3) towards p-nitrophenyl N-acyl glucosaminides highlights contrasting reactivity trends expected for families of β-glucosaminidase utilizing a mechanism of substrate-assisted catalysis (GH20) and those which do not (GH3): sharp decreases in activity with increasing N-acyl fluorination are observed in the case of the SpHex enzyme whereas negligible changes in activity are observed for ExoII [13].

Catalytic Residues

The key catalytic residues of GH20 enzymes are found in a conserved D-E amino acid pair. This catalytic diad is preceded in the primary sequence by the consensus H-x-G-G motif. The glutamate residue functions as the catalytic general acid/base. As these enzymes employ neighbouring group participation the preceding aspartate is not a nucleophile. Rather kinetic and crystallographic studies have shown that this residue orients and polarizes the N-acetyl residue [14]. It may function either as a general base by deprotonating the N-acetyl group in the intermediate and forming a neutral oxazoline intermediate, or alternatively it may electrostatically stabilize a positively charge oxazolinium ion intermediate. The N-acetyl group of the substrate is bound in a hydrophobic pocket defined by three conserved tryptophan residues. These three tryptophan residues define a compact pocket which does not accommodate (non-native) extended N-acyl side-chains as readily as the elongated hydrophobic pocket found in GH84 enzymes [15].

Three-dimensional structures

The first GH20 enzyme to have its structure determined was the Serratia marscescens chitobiase [16]. This enzyme's active site is located at the C-terminal end of the third of four protein domains, a (βα)8-barrel. On the basis of a structure of this enzyme in complex with the substrate chitobiose, the invariant Glu540 was identified as the likely catalytic general acid/base. Furthermore the N-acetyl group of the non-reducing N-acetylglucosamine residue was found to have its carbonyl oxygen atom suitably positioned to act as the nucleophile [14].

Ribbon diagram of SpHex with "NAG-thiazoline" bound in active site. The catalytic domain II is a (βα)8-barrel.

Family Firsts

First sterochemistry determination
The first determination of retaining stereochemistry for a known member of GH20 was on the Serratia marscescens enzyme [2]. The stereochemistry of hydrolysis of three different hexosaminidases (human placenta, jack bean, and bovine kidney) was shown by the Withers group in 1994 [17] and it is now generally assumed that some of these are GH20 enzymes.
First catalytic nucleophile identification
These enzymes employ neighbouring group participation using the substrate N-acetyl group. Prior to the advent of the CAZy system of classification, kinetic studies of the (likely GH20) β-N-hexosaminidases from Aspergillus oryzae [10] and Aspergillus niger [11] supported such a mechanism. This mechanism was suggested by analysis of both the 3-D structure of Serratia marcescens chitobiase [16] (by analogy with GH18 enzymes), through work in which the non-reducing end sugar was de-acetylated resulting in total loss in activity [2], and by potent inhibition of jack bean β-hexosaminidase by NAG-thiazoline [12].
First general acid/base residue identification
Inferred from the 3-D structure [16] and by analogy with structurally related GH18 chitinases.
First 3-D structure
The 3-D structure of the Serratia marscescens chitobiase [16].

References

  1. Tropak MB, Reid SP, Guiral M, Withers SG, and Mahuran D. (2004). Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients. J Biol Chem. 2004;279(14):13478-87. DOI:10.1074/jbc.M308523200 | PubMed ID:14724290 [Mahuran04]
  2. Drouillard S, Armand S, Davies GJ, Vorgias CE, and Henrissat B. (1997). Serratia marcescens chitobiase is a retaining glycosidase utilizing substrate acetamido group participation. Biochem J. 1997;328 ( Pt 3)(Pt 3):945-9. DOI:10.1042/bj3280945 | PubMed ID:9396742 [Armand1997]
  3. Cocker, D, Sinnott, ML (1976) Acetolysis of 2,4-Dinitrophenyl Glycopyranosides. J. C. S. Perkin II 90, 618-620.

    [Sinnott76]

    Link to article: DOI:10.1039/P29760000618

  4. Piszkiewicz, D, Bruice, T (1967) Glycoside Hydrolysis. I. Intramolecular Acetamido and Hydroxyl Group Catalysis in Glycoside Hydrolysis. J. Am. Chem. Soc. 89, 6237-6243.

    [Bruice67]

    Link to article: DOI:10.1021/ja01000a044

  5. Piszkiewicz, D, Bruice, T (1968) Glycoside Hydrolysis. II. Intramolecular Carboxyl and Acetamido Group Catalysis in β-Glycoside Hydrolysis. J. Am. Chem. Soc. 90, 2156-2163.

    [Bruice68_1]

    Link to article: DOI:10.1021/ja01010a038

  6. Piszkiewicz, D, Bruice, T (1968) Glycoside Hydrolysis. III. Intramolecular Acetamido Group Participation in the Specific Acid Catalyzed Hydrolysis of Methyl-2-Acetamido-2-deoxy-β-D-glucopyranoside. J. Am. Chem. Soc. 90, 5844-5848.

    [Bruice68_2]

    Link to article: DOI:10.1021/ja01023a032

  7. Lowe, G, Sheppard, G, Sinnott, ML, Williams, A, (1967) Lysozyme-Catalysed Hydrolysis of some 'β-Aryl Di-N-acetylchitobiosides. Biochem J. 104(3), 893-899.

    [Lowe67]

    Link to article: Biochem. J.

  8. Yamamoto K (1973). N-acyl specificity of Taka-N-acetyl-beta-D-glucosaminidase studied by synthetic substrate analogs. II. Preparation of some p-nitrophenyl 2-halogenoacetylamino-2-deoxy-beta-D-glucopyranosides and their susceptibility to enzymic hydrolysis. J Biochem. 1973;73(4):749-53. DOI:10.1093/oxfordjournals.jbchem.a130137 | PubMed ID:4720059 [Yamamoto73]
  9. Yamamoto K (1974). A quantitative approach to the evaluation of 2-acetamide substituent effects on the hydrolysis by Taka-N-acetyl-beta-D-glucosaminidase. Role of the substrate 2-acetamide group in the N-acyl specificity of the enzyme. J Biochem. 1974;76(2):385-90. DOI:10.1093/oxfordjournals.jbchem.a130580 | PubMed ID:4426886 [Yamamoto74]
  10. Mega T, Ikenaka T, and Matsushima Y. (1970). Studies on N-acetyl-beta-D-glucosaminidase of Aspergillus oryzae. I. Purification and characterization of N-acetyl-beta-D-glucosaminidase obtained from Takadiastase. J Biochem. 1970;68(1):109-17. | Google Books | Open Library PubMed ID:5452757 [Mega70]
  11. Jones CS and Kosman DJ. (1980). Purification, properties, kinetics, and mechanism of beta-N-acetylglucosamidase from Aspergillus niger. J Biol Chem. 1980;255(24):11861-9. | Google Books | Open Library PubMed ID:7440573 [Kosman80]
  12. Knapp, S, Vocadlo, DJ, Gao, Z, Kirk, B, Lou, J, Withers, SG (1996) NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation. J. Am. Chem. Soc. 118, 6804-6805.

    [Knapp96]

    Link to article: DOI:10.1021/ja960826u

  13. Vocadlo DJ and Withers SG. (2005). Detailed comparative analysis of the catalytic mechanisms of beta-N-acetylglucosaminidases from families 3 and 20 of glycoside hydrolases. Biochemistry. 2005;44(38):12809-18. DOI:10.1021/bi051121k | PubMed ID:16171396 [SGW05]
  14. Williams SJ, Mark BL, Vocadlo DJ, James MN, and Withers SG. (2002). Aspartate 313 in the Streptomyces plicatus hexosaminidase plays a critical role in substrate-assisted catalysis by orienting the 2-acetamido group and stabilizing the transition state. J Biol Chem. 2002;277(42):40055-65. DOI:10.1074/jbc.M206481200 | PubMed ID:12171933 [SJW2002]
  15. Macauley MS, Whitworth GE, Debowski AW, Chin D, and Vocadlo DJ. (2005). O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem. 2005;280(27):25313-22. DOI:10.1074/jbc.M413819200 | PubMed ID:15795231 [DJV2005]
  16. Tews I, Perrakis A, Oppenheim A, Dauter Z, Wilson KS, and Vorgias CE. (1996). Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease. Nat Struct Biol. 1996;3(7):638-48. DOI:10.1038/nsb0796-638 | PubMed ID:8673609 [Tews1996]
  17. Lai EC and Withers SG. (1994). Stereochemistry and kinetics of the hydration of 2-acetamido-D-glucal by beta-N-acetylhexosaminidases. Biochemistry. 1994;33(49):14743-9. DOI:10.1021/bi00253a012 | PubMed ID:7993902 [Lai]

All Medline abstracts: PubMed